Rockefeller Capital Management L.P. Invitae Corp Transaction History

Rockefeller Capital Management L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$1.71 - $3.61 $2,554 - $5,393	-1,494 Reduced 96.14%	60 $0
Q3 2022 Nov 02, 2022	SELL	$1.9 - $8.63 $2,888 - $13,117	-1,520 Reduced 49.45%	1,554 $3,000
Q2 2022 Aug 12, 2022	BUY	$2.13 - $9.01 $4,588 - $19,407	2,154 Added 234.13%	3,074 $7,000
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $1,613 - $4,006	257 Added 38.76%	920 $6,000
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $6,585 - $12,844	-448 Reduced 40.32%	663 $9,000

Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $12,738 - $17,606	-524 Reduced 32.05%	1,111 $30,000
Q2 2021 Aug 10, 2021	BUY	$26.09 - $40.4 $11,949 - $18,503	458 Added 38.91%	1,635 $55,000
Q1 2021 May 11, 2021	SELL	$33.06 - $56.93 $50,813 - $87,501	-1,537 Reduced 56.63%	1,177 $44,000
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $91,900 - $134,947	2,351 Added 647.66%	2,714 $112,000
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $10,320 - $16,215	363 New	363 $15,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.